London Stock Exchange welcomes HydrogenOne Capital Growth plc to the Premium Segment of the Main Market

HydrogenOne Capital Growth plc, the first London listed hydrogen fund, offers growth potential in clean hydrogen and related technologies. The Company offers investors diversified exposure to private equity and listed hydrogen companies on an international basis. The Company has today listed on the premium segment of London Stock Exchange's main market and qualifies for the Green Economy Mark.
 
The Investment Adviser, HydrogenOne Capital LLP is a specialist investor in the clean hydrogen sector, with a focus on unlocking profitable growth for investors whilst including a powerful environment – social – governance investment case into its decision-making and ownership process.  By excluding sectors such as fossil fuels producers, focusing strongly on energy transition themes, and proactively engaging with investments and other stakeholders more broadly, HydrogenOne Capital aims to deliver attractive returns and a positive environmental impact.
 
The IPO raised gross proceeds of £107 million, including a strategic cornerstone investment of £25 million by INEOS Energy. Panmure Gordon acted as sponsor, financial adviser and joint bookrunner and Kepler Cheuvreux acted as joint bookrunner to the Company.

Quick facts

Track
Market: Main Market
Instrument market cap (£m)
118.09
Listing/Admission to trading
30 Jul 2021
Looking for new and recent issues?

More recent

London International Shipping Week 2021

London International Shipping Week 2021 (LISW21) is seen throughout the world as the ‘must attend’ international maritime event of the year. London is the historic centre of global trade and world shipping and stands at the heart of international commerce. Its long-standing maritime institutions have been servicing the global shipping industry for centuries and that role co

Learn more
57.28
London Stock Exchange welcomes LungLife AI

London Stock Exchange welcomes LungLife AI, Inc. to trading on AIM. In July 2021 LungLife successfully raised gross proceeds of £17 million and the Company’s market capitalisation on admission was £45 million with a free float of 50.6%. 

LungLife AI’s mission is to make a significant impact in the early detection of lung cancer. The Company is a develop

Learn more
33.56
London Stock Exchange welcomes Likewise Group plc to AIM

Likewise is a UK distributor of both domestic and commercial floorcoverings and matting. It is challenging the established competitors in the industry by providing access to a wide choice of flooring from multiple manufacturers across the globe at competitive prices for its customers. The Directors believe they have an opportunity to build a

Learn more
144.88
London Stock Exchange welcomes BiVictriX Therapeutics plc

London Stock Exchange today welcomes BiVictriX Therapeutics plc (“BiVictriX”), a rapidly emerging drug discovery and development company that begins trading on AIM under the ticker symbol BVX, following a successful initial public offering.

BiVictriX has successfully raised gross proceeds of £

Learn more